RecruitingNCT07325266
Apremilast doses and alcohol cravings in adults with alcohol use disorder
About this title
Read the official source — NCT07325266Medication studyAges 21+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 21 years.
- Listed locations
- Los Angeles and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 3, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 100
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 21 Years
- Official registry ID
- NCT07325266
- Official title
Show the full official title
Human Laboratory Study of Apremilast for Alcohol Use Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Los Angeles · Aurora · Charlottesville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.
Does this study involve medication?
Yes. The study involves medication, including Placebo and Apremilast.
Who can participate?
Listed age limits: from 21 years.
Is this study still recruiting?
The registry lists this study as recruiting.
